Vanucizumab Antibody
Vanucizumab is a humanized bispecific monoclonal antibody designed for oncology research, targeting both VEGF-A and Angiopoietin-2 to inhibit tumor angiogenesis. It is utilized in preclinical studies for investigating anti-cancer mechanisms in advanced solid tumor models, both in vitro and in vivo.
Product Specifications
Product Name Alternative
RO5520985, RO 5520985, Anti-Human VEGFA Recombinant Antibody
Target
VEGFR, Tie-2
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
14.97 mg/mL
Purity
>95.0% (May vary between batches)
Molecular Weight
146.89 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62084R-PE-Cy5-01 20 µL
Apolipoprotein CI/APOC1 Recombinant Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details bsm-62084R-PE-Cy5-02 100 µL
Apolipoprotein CI/APOC1 Recombinant Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details